Study of TLC-2716 for high triglycerides and fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests an investigational drug called TLC-2716 for people with very high triglycerides and a type of fatty liver disease (NAFLD or NASH). The goal is to see if it is safe and can help lower fat levels in the blood and liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a body mass index (BMI) of 28 or higher
- Your fasting triglycerides are 350 mg/dL or more
- You have been diagnosed with fatty liver disease (NAFLD/NASH) in the last 5 years
- You either do not have diabetes, or if you do, your blood sugar control (HbA1c) is below 9.5%
- You have not lost more than 5% of your body weight in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This trial tests a potential new medicine (NNC4005-0001) for liver disease in adults who have extra body weight and excess fat in their liver. It aims to see if the medicine can help improve liver health.
This Phase 2 study tests whether SNP-610 (or a placebo) can improve non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. It also checks safety by comparing outcomes between the two groups.
This trial tests an experimental pill called CS060380 for people with NASH (a type of fatty liver disease that can cause liver damage). You may qualify if you have a liver biopsy showing NASH with early-to-moderate scarring, or an MRI showing at least 10% liver fat, and your liver enzymes are stable.
This early-phase trial tests an experimental drug called FXR0906 in healthy adults who have elevated triglycerides (a type of fat in the blood). It aims to see if the drug is safe and how it affects cholesterol and fat levels, which may help prevent heart disease.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.